Amphastar Pharmaceuticals Receives FDA Approval for Dextrose Injection

Amphastar Pharmaceuticals Receives FDA Approval for Dextrose Injection

datetime
Associated Press
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (“FDA”) approved the Company’s Abbreviated New Drug Application (“ANDA”) for Dextrose injection 50% in the 50 mL Luer-Jet® Prefilled Syringe System.
Read Article